The signing ceremony took place 2-3 of May 2023 in Helsinki and marks the start of another decade for the Nordic EMBL Partnership for Molecular Medicine (2023-2033). The partnership is a network of national research centres across the Nordics and the European Molecular Biology Laboratory (EMBL), with complementary research expertise at the forefront of molecular medicine research. NCMM is the Norwegian node of the Partnership, together with FIMM in Finland, MIMS in Sweden and DANDRITE in Denmark.
Directors from each node of the Nordic EMBL Partnership and the rectors of the hosting universities signed the agreement in the University Great Hall of the University of Helsinki. NCMM Director Janna Saarela and UiO rector Svein Stølen signed on behalf of NCMM and UiO.
– The Nordic EMBL Partnership is a unique network sharing a common vision of implementing excellence in research. The partnership units operate as green houses for talented young scientists, to foster collaboration and impactful research in Molecular Medicine within their host environments and across nodes. NCMM looks forward to a further 10 years together with our sister nodes and to the many opportunities for training, research collaboration and education that are to come, says Janna Saarela.
The celebrations also included a Scientific Symposium to showcase some of the Partnerships excellent research and achievements. Here, Janna Saarela highlighted the young talent that NCMM fosters, by presenting some of the work performed by early career researchers at NCMM, with a focus on inherited errors of immunity.
You can read more about the event on the Nordic EMBL Partnership website.